Picard Medical not aware of undisclosed material change to account for trading

Picard Medical (PMI), parent company of SynCardia Systems, maker of the first U.S. and Canadian commercially-approved total artificial heart, announced that it is not aware of any undisclosed material change in the company’s operations or financial condition, that would account for the recent volatility in its stock price. “The company remains focused on executing its strategic and operational priorities and will continue to comply with all disclosure obligations under applicable securities laws,” Picard Medical stated.